Yuan et al. created a multivalent bi-specific nanobioconjugate engager (mBiNE) to promote selective and enhanced eradication of cancer cells by means of simultaneously targeting HER2 expressed by cancer cells and pro-phagocytosis signaling mediated by calreticulin [54]. This evidence concerns the gene ERBB2 and cancer.